PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8150120

Quantification of spermatogenesis by dual-parameter flow cytometry.

A Hittmair·H Rogatsch·G Mikuz·H Feichtinger
View original source ↗Export metadata ↓

Abstract

OBJECTIVE: To investigate the usefulness of dual-parameter flow cytometry of testicular fine-needle aspirates for the quantification of spermatogenesis. Immunofluorescence staining for vimentin was introduced to discriminate vimentin-negative germ cells from vimentin-positive stromal cells. The results of flow cytometry were compared with testicular morphology and immunohistochemistry in cases of regular and disturbed germ cell maturation. DESIGN: Testicular fine-needle aspiration and surgical biopsy were performed in 50 autopsy cases. The fine-needle aspirates were double stained for the intermediate filament vimentin by indirect immunofluorescence and DNA propidium iodide and analyzed by flow cytometry. Surgical biopsies were examined by light microscopy. The distribution of vimentin-positive cells was evaluated by immunohistochemistry. RESULTS: A comparison of morphology and flow cytometric analysis yielded characteristic quantitative distribution patterns of the different germ cell and somatic cell populations in regular and disturbed spermatogenesis. All three ploidy compartments of the germ epithelium correlated with high statistical significance with the respective histologic diagnoses. Moreover, a marked quantitative increase of stromal cells could be demonstrated in spermatogenetic disorders. CONCLUSIONS: The simultaneous analysis of the cellular DNA content and the intermediate filament vimentin by flow cytometry enables a detailed investigation of spermatogenetic disorders. Quantitative changes of the relationships between germ cells and somatic cells can be selectively investigated.

Explore related subjects

Biopsy, NeedleFlow CytometryFluorescent Antibody TechniqueHumansImmunohistochemistryMalePloidiesSpermatogenesisSpermatozoaTestisVimentinJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Hittmair, H Rogatsch, G Mikuz, H Feichtinger. 1994. Quantification of spermatogenesis by dual-parameter flow cytometry.. https://doi.org/10.1016/s0015-0282(16)56656-4

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Targeting difficult accessible breast lesions: MRI-guided needle localization using a freehand technique in a 3.0 T closed bore magnet.

PURPOSE: To report the accuracy of magnetic resonance imaging (MRI)-guided needle localization for diagnosis of MRI detected suspicious breast lesions located in difficult accessible regions of the breast, using the freehand method in a 3.0 T closed bore magnet. MATERIALS AND METHODS: In five patients with five MRI-only breast lesions underwent MRI-guided needle localization for histopathologic evaluation of the lesions. All interventional procedures were performed in a 3.0 T MRI system with the patient in prone position and by using a dedicated phased array breast coil. MRI-guided needle localizations were performed by using a freehand technique. In our study, the high-resolution scan allowed preprocedural localization of all lesions without use of contrast enhancement. In all cases contrast-enhanced MRI was performed after insertion of the wire to confirm the tip of the wire in direct contact with the enhancing lesion. RESULTS: Needle localizations were performed in five patients. Histopathologic evaluation of tissue after surgery excision biopsy revealed one lymph node, three invasive ductal carcinoma and one ductal carcinoma in situ. Lesion size varied from 6 to 30 mm. Mean duration time was 25 min. No complications occurred during the intervention method. In the patient with the benign lesion control MRI of the breast after 6 months confirmed lesion removal. CONCLUSIONS: MRI-guided needle localization by using a freehand technique in a 3.0 T closed bore magnet is a safe and accurate method for diagnosis of difficult accessible breast lesions only visible on MRI.

Biopsy, Needle↗